Top Markets
Coin of the day
Biocure Technology Inc. Biocure Technology Inc.

Biocure Technology Inc.

CURE
株式のランク #39914
Biocure Technology Inc., operating with its subsidiary, focuses on the creation... Biocure Technology Inc., operating with its subsidiary, focuses on the creation and market introduction of biopharmaceutical innovations, particularly those involving recombinant technologies and ranibizumab. The company's current development pipeline includes: Interferons-ß, aimed at treating multiple sclerosis. Ranibizumab, a monoclonal antibody fragment designed to address macular degeneration and a related eye condition known as macular edema. Filgrastim, which targets neutropenia – a deficiency of white blood cells that can arise from cancer, bone marrow transplants, chemotherapy, or other medical issues. Additionally, Biocure is conducting research and development into several promising areas: CAR T-cell therapy, which works by identifying and eradicating cancer cells. A vaccine against foot and mouth disease. Various products for promoting hair growth. The firm was established in 2005 and its corporate headquarters are located in Vancouver, Canada.
株価
$0.00366968
最終同期: 2024-07-12
時価総額
$299.46K
変化(1日)
-66.77%
変化(1年)
0.00%
CA
取引 Biocure Technology Inc. (CURE)

カテゴリー

Biocure Technology Inc.(CURE)の株価履歴
終値の最高値: $0.00 (2024-07-01)

終値の最安値: $0.01 (2009-03-01)
Biocure Technology Inc. の株価履歴(2009 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2024 -66.52%
2023 45.61%
2022 -93.00%
2021 -11.53%
2020 -23.85%
2019 -54.33%
2018 42.23%
2017 3,176.92%
2016 2.72%
2015 68.45%
2014 -68.19%
2013 -16.07%
2012 -65.37%
2011 376.76%
2010 -26.05%
2009 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$517.18 32.51%
US
$857.76 31.47%
NL
$739.76 8.31%
CH
$1.07K -6.40%
KR
$258.70 14.29%
BE